Products
Platform
Research
Market
Learn
IPO
Compare UTI Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.26 | 1.87 |
NAV | ₹290.29 | ₹40.48 |
Fund Started | 01 Aug 2005 | 25 Jun 2018 |
Fund Size | ₹1124.88 Cr | ₹6437.36 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.26
1.87
NAV
₹290.29
₹40.48
Fund Started
01 Aug 2005
25 Jun 2018
Fund Size
₹1124.88 Cr
₹6437.36 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 2.78% | 6.25% |
3 Year | 23.94% | 27.27% |
5 Year | 17.64% | 20.64% |
1 Year
2.78%
6.25%
3 Year
23.94%
27.27%
5 Year
17.64%
20.64%
Holding Analysis
Equity | 98.12% | 97.10% |
Cash | 1.87% | 2.90% |
Equity
98.12%
97.10%
Cash
1.87%
2.90%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.77% |
Ajanta Pharma Ltd. | 6.25% |
Lupin Ltd. | 5.58% |
Glenmark Pharmaceuticals Ltd. | 4.12% |
Cipla Ltd. | 3.74% |
Procter & Gamble Health Ltd. | 3.67% |
Gland Pharma Ltd. | 3.65% |
Apollo Hospitals Enterprise Ltd. | 3.62% |
Dr. Reddy's Laboratories Ltd. | 3.57% |
Alkem Laboratories Ltd. | 3.52% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.88% |
Dr. Reddy's Laboratories Ltd. | 9.42% |
Divi's Laboratories Ltd. | 8.50% |
Aurobindo Pharma Ltd. | 7.62% |
Cipla Ltd. | 6.61% |
Lupin Ltd. | 5.40% |
Alkem Laboratories Ltd. | 3.98% |
Biocon Ltd. | 3.28% |
Mankind Pharma Ltd. | 2.79% |
Zydus Lifesciences Ltd. | 2.67% |
Fund Manager
Name | Kamal Gada | Dharmesh Kakkad |
Start Date | 02 May 2022 | 23 Feb 2021 |
Name
Kamal Gada
Dharmesh Kakkad
Start Date
02 May 2022
23 Feb 2021
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 01 Aug 2005 | 25 Jun 2018 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
01 Aug 2005
25 Jun 2018